Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Robert K. who wrote (9930)	5/13/1999 10:07:00 AM
From: aknahow	Respond to of 17367

Bob, are there milestones for P III with GNE? I don't think there are. XOMA is a 25% partner with its expenses paid. I think they would have played up any milestone payments as good p.r. if there really were any. Don't forget MacCamants letter, as posted here made reference to I-Prex. Thought it was interesting, he chose to mention it, rather than Mycoprex, or both. I posted my thoughts on this and still wonder what was said to him. A good partnership deal might get XOMA to move.